D. Pratico et al., Down's syndrome is associated with increased 8,12-iso-iPF(2 alpha)-VI levels: Evidence for enhanced lipid peroxidation in vivo, ANN NEUROL, 48(5), 2000, pp. 795-798
postmortem and in vitro studies have shown that oxidative stress plays a ro
le in the pathogenesis of many of the clinical features of Down's syndrome.
The isoprostane 8,12-iso-iPF(2 alpha)-VI is a specific marker of lipid per
oxidation. We found elevated levels of this isoprostane in urine samples of
subjects with Down's syndrome compared with those of matched controls, whi
ch correlated with the duration of the disease. These results suggest that
increased in vivo lipid peroxidation is a prominent component early in the
course of Down's syndrome.